Scholars@Duke
Journal cover image

EP08.01-045 The Impact of Current Smoking Status at Initiation of Immune Checkpoint Inhibitor Therapy on Tumor Mutation Burden and Survival

Publication ,  Conference
Wu, JT; La, J; Han, S; Das, M; Glover, M; Scobie, M; Brophy, M; Do, N; Ahmed, S; Fillmore, N; Kelley, M
Published in: Journal of Thoracic Oncology
September 2022
Published version (DOI) Publisher Link

Duke Scholars

Michael John Kelley
Author Michael John Kelley Medicine, Medical Oncology

Published In

Journal of Thoracic Oncology

DOI

10.1016/j.jtho.2022.07.617

ISSN

1556-0864

Publication Date

September 2022

Volume

17

Issue

9

Start / End Page

S359 / S360

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wu, J. T., La, J., Han, S., Das, M., Glover, M., Scobie, M., … Kelley, M. (2022). EP08.01-045 The Impact of Current Smoking Status at Initiation of Immune Checkpoint Inhibitor Therapy on Tumor Mutation Burden and Survival. In Journal of Thoracic Oncology (Vol. 17, pp. S359–S360). Elsevier BV. https://doi.org/10.1016/j.jtho.2022.07.617
Wu, J. T., J. La, S. Han, M. Das, M. Glover, M. Scobie, M. Brophy, et al. “EP08.01-045 The Impact of Current Smoking Status at Initiation of Immune Checkpoint Inhibitor Therapy on Tumor Mutation Burden and Survival.” In Journal of Thoracic Oncology, 17:S359–60. Elsevier BV, 2022. https://doi.org/10.1016/j.jtho.2022.07.617.
Wu JT, La J, Han S, Das M, Glover M, Scobie M, et al. EP08.01-045 The Impact of Current Smoking Status at Initiation of Immune Checkpoint Inhibitor Therapy on Tumor Mutation Burden and Survival. In: Journal of Thoracic Oncology. Elsevier BV; 2022. p. S359–60.
Wu, J. T., et al. “EP08.01-045 The Impact of Current Smoking Status at Initiation of Immune Checkpoint Inhibitor Therapy on Tumor Mutation Burden and Survival.” Journal of Thoracic Oncology, vol. 17, no. 9, Elsevier BV, 2022, pp. S359–60. Crossref, doi:10.1016/j.jtho.2022.07.617.
Wu JT, La J, Han S, Das M, Glover M, Scobie M, Brophy M, Do N, Ahmed S, Fillmore N, Kelley M. EP08.01-045 The Impact of Current Smoking Status at Initiation of Immune Checkpoint Inhibitor Therapy on Tumor Mutation Burden and Survival. Journal of Thoracic Oncology. Elsevier BV; 2022. p. S359–S360.
Journal cover image

Published In

Journal of Thoracic Oncology

DOI

10.1016/j.jtho.2022.07.617

ISSN

1556-0864

Publication Date

September 2022

Volume

17

Issue

9

Start / End Page

S359 / S360

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology